Ali, F.M., Salek, M.S., Finlay, A.Y. ![]() |
|
Bhatti, Zaheer Uddin, Finlay, Andrew Yule ![]() |
![]() |
Raja, Aditya, O'Neill, Claire ![]() |
|
Harun, Nur Ainita, Salek, Mir-saeed, Piguet, Vincent and Finlay, Andrew Yule ![]() |
![]() |
Golics, Catherine Jane, Basra, Mohammad Khurshid Azam, Finlay, Andrew Yule ![]() |
![]() |
Allen, Nicola, Pichler, Franz, Wang, Tina, Patel, Sundip and Salek, Mir-saeed 2013. Development of archetypes for non-ranking classification and comparison of European National Health Technology Assessment systems. Health Policy 113 (3) , pp. 305-312. 10.1016/j.healthpol.2013.09.007 |
![]() |
Basra, M. K. A., Gada, V., Ungaro, Shaun, Finlay, Andrew Yule ![]() |
![]() |
Salek, Mir-saeed, Dumrongprat, Kuntika and Nathisuwan, S. 2013. Cost-effectiveness of CYP2C9 and VKORC1 genetic testing to predict warfarin guided dose in Thai population [Abstract]. International Journal of Clinical Pharmacy 35 (5) , p. 1005. 10.1007/s11096-013-9801-0 |
![]() |
Salek, Mir-saeed and Zawaneh, Yousef Z. 2013. Real world data in Europe: access, availability, and possible applications of population based cancer registries and diabetes databases [Abstract]. International Journal of Clinical Pharmacy 35 (5) , p. 970. 10.1007/s11096-013-9801-0 |
![]() |
Salek, Mir-saeed and Chong, Huey Yi 2013. Evaluation of the adequacy of patient-reported outcome measures used in atopic dermatitis: a systematic review [Abstract]. International Journal of Clinical Pharmacy 35 (5) , p. 969. 10.1007/s11096-013-9801-0 |
![]() |
Salek, Mir-saeed and Seglah, Sabrina Elikem 2013. Critical evaluation of the national health insurance scheme in Ghana: the perspective of the stakeholders [Abstract]. International Journal of Clinical Pharmacy 35 (5) , p. 976. 10.1007/s11096-013-9801-0 |
![]() |
Golics, Catherine Jane, Basra, Mohammad K. A., Finlay, Andrew Yule ![]() |
![]() |
Salek, Mir-saeed, Ngugi, N. M. and Ehling, M. 2013. The effectiveness of erythropoiesis stimulating agents (ESAs) in the treatment of myelodysplastic syndromes (MDS): systematic review and meta analysis [Abstract]. International Journal of Clinical Pharmacy 35 (5) , p. 1006. 10.1007/s11096-013-9801-0 |
![]() |
Salek, Mir-saeed, Jung, S., Brincat-Ruffini, L. A., MacFarlane, L., Lewis-Jones, M. S., Basra, M. K. A. and Finlay, Andrew Yule ![]() |
![]() |
Prinsen, C. A. C., de Korte, J., Augustin, M., Sampogna, F., Salek, Mir-saeed, Basra, M. K. A., Holm, E. A., Nijsten, T. E. C. and The EADV Taskforce on Quality of Life 2013. Measurement of health-related quality of life in dermatological research and practice: outcome of the EADV Taskforce on Quality of Life. Journal of the European Academy of Dermatology and Venereology 27 (10) , pp. 1195-1203. 10.1111/jdv.12090 |
![]() |
Leong, James, McAuslane, Neil, Walker, Stuart and Salek, Mir-saeed 2013. Is there a need for a universal benefit-risk assessment framework for medicines? Regulatory and industry perspectives. Pharmacoepidemiology and Drug Safety 22 (9) , pp. 1004-1012. 10.1002/pds.3464 |
![]() |
Dodington, Sean R., Basra, M. K. A., Finlay, Andrew Yule ![]() |
![]() |
Salek, Mir-saeed and Kamudoni, Paul 2013. Quality of life measurement in dermatology consultation: impact on patient reported outcomes. Giornale Italiano di Dermatologia e Venereologia 148 (3) , pp. 263-275. |
![]() |
Salek, Mir-saeed, Ionova, Tatyana and Oliva, Esther 2013. Patients' needs in hematology: whose perspectives? Haematologica 98 (6) , pp. 828-830. 10.3324/haematol.2013.090399 |
![]() |
Bhatti, Zaheer Uddin, Salek, Mir-saeed, Bolton, Charlotte E., George, Lindsay, Halcox, Julian P. J., Jones, Sharon M., Ketchell, Ian R., Moore, Richard H., Sabit, Ramsey, Piguet, Vincent and Finlay, Andrew Yule ![]() |
|
Basra, Mohamed K. A., Finlay, Andrew Yule ![]() |
![]() |
Basra, Mohamed K. A., Salek, Mir-saeed and Finlay, Andrew Yule ![]() |
![]() |
Deger, Melike, Eisterer, W., Kutikova, L. and Salek, Mir-saeed 2013. Hemoglobin level at initiation of darbepoetin alfa: impact on need for transfusion and associated costs in chemotherapy-induced anemia treatment in Europe. Supportive Care in Cancer 21 (2) , pp. 485-493. 10.1007/s00520-012-1538-0 |
|
Chomienne, Christine, Guenova, Margarita, Hagenbeek, Anton, Lacombe, Catherine, McCann, Shaun, Salek, Mir-saeed, Geissler, Jan and van der Beek, Ineke 2013. Quality of Life in hematology: European Hematology Association theme of the year ... and years to come. Haematologica 98 (1) , pp. 2-3. 10.3324/haematol.2012.080796 |
![]() |
Golics, Catherine Jane, Basra, Mohammad, Salek, Mir-saeed and Finlay, Andrew Yule ![]() |
![]() |
Polek, Barbara, Roach, M. J., Andrews, William T., Ehling, Manfred and Salek, Mir-saeed 2013. Burden of Friedreich’s Ataxia to the patients and healthcare systems in the United States and Canada. Frontiers in Pharmacology 4 , 66. 10.3389/fphar.2013.00066 |
|
Salek, Mir-saeed, Schmidt-Rimpler, C., Wimberger, P., Gilet, H. and Parsons, S. L. 2012. Converting EORTC QOl-C30 Scores to Utility Values: Is it Plausible? [Abstract]. Value in Health 15 (7) , A478. 10.1016/j.jval.2012.08.1563 |
![]() |
Salek, Mir-saeed, Deger, Melike, Wimberger, P., Gilet, H. and Parsons, S. L. 2012. Quality of Life in Patients With Malignant Ascites After Treatment With Catumaxomab: A Multicenter Phase II/III Study Comparing Paracentesis Plus Catumaxomab With Paracentesis Alone [Abstract]. Value in Health 15 (7) , A430-A431. 10.1016/j.jval.2012.08.2157 |
![]() |
Finlay, Andrew Yule ![]() |
![]() |
Basra, Mohamed K. A., Pereira, F., Finlay, Andrew Yule ![]() |
![]() |
Basra, Mohamed K. A., Cruz, P., Finlay, Andrew Yule ![]() |
![]() |
Kamudoni, Paul, Salek, Mir-saeed, Mueller, B. and Mueller, C. 2012. Hyperhidrosis Quality of Life Index (Hidroqol (c)): a novel patient reported outcome measure in hyperhidrosis [Abstract]. Journal of Investigative Dermatology 132 (S2) , S73. 10.1038/jid.2012.300 |
![]() |
Golics, Catherine Jane, Basra, Mohamed K. A., Salek, Mir-saeed and Finlay, Andrew Yule ![]() |
![]() |
Pereira, F. R. A., Basra, Mohamed K. A., Finlay, Andrew Yule ![]() |
![]() |
Salek, Mir-saeed, Patel, Shriti and Pichler, F. 2012. Comparisons of pharmaceutical registration to reimbursement in the 30 European Economic area countries [Abstract]. International Journal of Clinical Pharmacy 34 (1) , p. 222. 10.1007/s11096-011-9602-2 |
![]() |
Salek, Mir-saeed, Siyani, S., Basra, M. K. and Finlay, Andrew Yule ![]() |
![]() |
Al-Essa, Reem, Salek, Mir-saeed and Walker, Stuart 2012. Regulatory review process in the Gulf Cooperation Council states: similarities and differences. Drug Information Journal 46 (1) , pp. 65-72. 10.1177/0092861511427674 |
![]() |
Salek, Mir-saeed, Mallia-Milanes, Andrea, McAuslane, Neil and Walker, Stuart 2012. Development and application of scorecards to assess the quality of a regulatory submission and its review. Drug Information Journal 46 (1) , pp. 73-83. 10.1177/0092861511427694 |
![]() |
Al-Essa, Reem, Salek, Mir-saeed and Walker, Stuart 2012. An appraisal of good regulatory review practices in the Gulf Cooperation Council states. Drug Information Journal 46 (1) , pp. 57-64. 10.1177/0092861511427110 |
![]() |
Salek, Mir-saeed, Jones, S., Rezaie, M., Davies, C., Mills, R. and Ketchell, Ian 2012. Do patient-reported outcomes have a role in the management of patients with cystic fibrosis? Frontiers in Pharmacology 3 (38) 10.3389/fphar.2012.00038 |
|
Finlay, Andrew Yule ![]() |
![]() |
Basra, M., Salek, Mir-saeed, Tanweer, Zahira, Fenech, Daniela, Howe, A., Mahbouba, Tina, Golics, Catherine Jane, Piguet, Vincent and Finlay, Andrew Yule ![]() |
![]() |
Basra, M., Siyani, Seetal, Salek, Mir-saeed, Piguet, Vincent and Finlay, Andrew Yule ![]() |
![]() |
Basra, M., Zammit, Anne Marie, Salek, Mir-saeed and Finlay, Andrew Yule ![]() |
![]() |
Golics, Catherine Jane, Basra, M., Salek, Mir-saeed and Finlay, Andrew Yule ![]() |
![]() |
Salek, Mir-saeed, Abdulla, A. and Raasch, R. 2011. How far are the pharmacists in North Carolina prepared to extend their role in immunisation? [Abstract]. International Journal of Clinical Pharmacy 33 (2) , pp. 431-432. 10.1007/s11096-011-9481-6 |
![]() |
Salek, Mir-saeed, Fairfax, M. and Basra, M. 2011. Psychometric evaluation of a family psoriasis specific quality of life instrument [Abstract]. International Journal of Clinical Pharmacy 33 (2) , pp. 409-410. 10.1007/s11096-011-9481-6 |
![]() |
Salek, Mir-saeed, Allen, N. and Pichler, F. 2011. Categorisation of HTA agencies and their decision-making systems from regulatory approval to reimbursement [Abstract]. International Journal of Clinical Pharmacy 33 (2) , p. 400. 10.1007/s11096-011-9481-6 |
![]() |
Salek, Mir-saeed, McKnight, R. and Basra, M. 2011. How much money and time are the family of dermatology patients willing to trade off for improved quality of life? [Abstract]. International Journal of Clinical Pharmacy 33 (2) , pp. 399-400. 10.1007/s11096-011-9481-6 |
![]() |
Bhatti, Zaheer Uddin, Salek, Mir-saeed and Finlay, Andrew Yule ![]() |
![]() |
Bhatti, Zaheer Uddin, Salek, Mir-saeed and Finlay, Andrew Yule ![]() |
![]() |
Finlay, Andrew Yule ![]() |
![]() |
Bhatti, Zaheer Uddin, Salek, Mir-saeed and Finlay, Andrew Yule ![]() |
![]() |
Salek, Mir-saeed 2011. Potential long term benefits from early assessment of disease impact on QoL in routine practice [Abstract]. Acta Dermato-Venereologica 91 (2) , p. 220. |
![]() |
Golics, Catherine Jane, Basra, M. K. A., Salek, Mir-saeed and Finlay, Andrew Yule ![]() |
![]() |
Basra, Muhammed A. K., Salek, Mir-saeed, Fenech, D., Howe, A., Mahbouba, Tina, Golics, Catherine Jane and Finlay, Andrew Yule ![]() |
![]() |
Bhatti, Zaheer Uddin, Salek, Mir-saeed and Finlay, Andrew Yule ![]() |
![]() |
Valentin, M., Neises, G. and Salek, Mir-saeed 2011. Did Iqwig's drug appraisals in connection with G-BA'S directives change prescribing behavior of German physicians? Value in Health 14 (7) , A351. 10.1016/j.jval.2011.08.651 |
![]() |
Hajjaj, Fadi M, Salek, Mir-saeed, Basra, M. K. A. and Finlay, Andrew Yule ![]() |
![]() |
Basra, M. K., Williams, Owain, McKnight, Rhiannon and Salek, Mir-saeed 2010. A Preference Based Approach to Assess Quality of Life of Family Members of Patients with Inflammatory Skin Diseases [Abstract]. Journal of Investigative Dermatology 130 (S2) , S71. 10.1038/jid.2010.238 |
![]() |
Bhatti, Zaheer Uddin, Salek, Mir-saeed and Finlay, Andrew Yule ![]() |
![]() |
Hajjaj, F., Salek, Mir-saeed, Basra, M. K. A. and Finlay, Andrew Yule ![]() |
![]() |
Basra, M. K. A., Camilleri, L., Salek, Mir-saeed and Finlay, Andrew Yule ![]() |
![]() |
Hajjaj, F. M., Salek, Mir-saeed, Basra, M. K. A. and Finlay, Andrew Yule ![]() |
![]() |
Salek, Mir-saeed, Sanghvi, S., Rodgers, J. and Montague, D. 2010. Evaluation of the use and efficacy of heparin nomograms in a university-teaching hospital in North Carolina [Abstract]. Pharmacy World and Science 32 (2) , p. 263. 10.1007/s11096-010-9378-9 |
![]() |
Salek, Mir-saeed, Modi, A, Hansen, R. A. and Wei, D. 2010. Reducing repeat medication errors in nursing homes [Abstract]. Pharmacy World and Science 32 (2) , pp. 242-243. 10.1007/s11096-010-9378-9 |
![]() |
Salek, Mir-saeed, Mahbouba, T., Basra, M., Golicks, C. and Finlay, Andrew ![]() |
![]() |
Salek, Mir-saeed, Sturkey, R., Basra, M. and Finlay, Andrew Yule ![]() |
![]() |
Hajjaj, F. M., Salek, Mir-saeed, Basra, M and Finlay, Andrew Yule ![]() |
![]() |
Salek, Mir-saeed, Kamau, P., McAuslane, N, Pichler, F. and Walker, Stuart 2010. Is simultaneous submission and regulatory approval a reality towards faster patient access to medicines in the ICH region and beyond? [Abstract]. Pharmacy World and Science 32 (2) , pp. 218-219. 10.1007/s11096-010-9378-9 |
![]() |
Golics, Catherine Jane, Basra, M. K. A., Finlay, Andrew Yule ![]() |
![]() |
Tlusta, Eva, Zarubova, Jana, Simko, Julius, Hojdikova, Helena, Salek, Mir-saeed and Vlcek, Jiri 2009. Clinical and demographic characteristics predicting QOL in patients with epilepsy in the Czech Republic: how this can influence practice. Seizure 18 (2) , pp. 85-89. 10.1016/j.seizure.2008.06.006 |
![]() |
Almotiri, Badreea and Salek, Mir-saeed 2009. Health care professionals attitude towards noncompliance with drug treatment [Abstract]. Pharmacy World & Science 31 (2) , p. 247. 10.1007/s11096-008-9274-8 |
![]() |
Basra, M. K., Sturkey, Rebeca L., Salek, Mir-saeed and Finlay, Andrew Yule ![]() |
![]() |
Bhatti, Zaheer Uddin, Finlay, Andrew Yule ![]() |
![]() |
Bhatti, Zaheer Uddin, Finlay, Andrew Yule ![]() |
![]() |
Hajjaj, Fadi M., Basra, M. K., Salek, Mir-saeed and Finlay, Andrew Yule ![]() |
![]() |
Salek, Mir-saeed, Golicks, C., Basra, M. and Finlay, Andrew Yule ![]() |
![]() |
Salek, Mir-saeed, Khalaf, M. and Ives, T. 2009. Patterns of obtaining prescribed medicines for chronic diseases among Medicaid patients [Abstract]. Pharmacy World & Science 31 (2) , pp. 311-312. 10.1007/s11096-008-9274-8 |
![]() |
Salek, Mir-saeed, Loh, E. A. T., McAuslane, N., Read, K. and Walker, Stuart 2009. Factors influencing delays of pharmaceutical product registration in new markets: a global concern [Abstract]. Pharmacy World & Science 31 (2) , pp. 277-278. 10.1007/s11096-008-9274-8 |
![]() |
Salek, Mir-saeed, Rehman, L. and Eckel, S. 2009. The impact of a reduction in the number of automated alerts on pharmacist's response to drug-drug interactions [Abstract]. Pharmacy World & Science 31 (2) , p. 249. 10.1007/s11096-008-9274-8 |
![]() |
Salek, Mir-saeed, Watson, S. and Ketchell, Ian 2009. Health-related quality of life in adult cystic fibrosis: development of a new measure [Abstract]. Pharmacy World & Science 31 (2) , pp. 250-251. 10.1007/s11096-008-9274-8 |
![]() |
Salek, Mir-saeed, Wellum, A., Rogers, J. E. and MacKay, J. 2009. Is the dose escalation of statins an appropriate management strategy for lowering low-density lipoprotein? [Abstract]. Pharmacy World & Science 31 (2) , p. 329. 10.1007/s11096-008-9274-8 |
![]() |
Walker, S., McAuslane, N., Liberti, L. and Salek, Sam 2009. Measuring Benefit and Balancing Risk: Strategies for the Benefit-Risk Assessment of New Medicines in a Risk-Averse Environment. Clinical Pharmacology and Therapeutics 85 (3) , pp. 241-246. 10.1038/clpt.2008.277 |
![]() |
Walker, S., McAuslane, N., Liberti, L. and Salek, Mir-saeed 2009. Measuring benefit and balancing risk: strategies for the benefit–risk assessment of new medicines in a risk-averse environment. Clinical Pharmacology and Therapeutics 85 (3) , pp. 241-246. 10.1038/clpt.2008.277 |
![]() |
Salek, Sam, Gill, N., Gates, B., Rice, L. and Weeks, D. 2008. Evaluation of the effectiveness of sliding scale insulin for glycemic control in the home care setting [Abstract]. Pharmacy World & Science 30 (5) , p. 709. 10.1007/s11096-008-9226-3 |
![]() |
Salek, Sam, Mallia-Milanes, A., McAuslane, N. and Walker, Stuart 2008. Can systematic use of scorecards be of value in the evaluation of the quality of industry submissions and their regulatory review? [Abstract]. Pharmacy World and Science 30 (5) , p. 721. 10.1007/s11096-008-9226-3 |
![]() |
Salek, Sam, Morgan, L., McAuslane, N., Read, K. and Walker, Stuart 2008. Companies submission strategies and regulatory approval times greatly influence patient access to medicine [Abstract]. Pharmacy World and Science 30 (5) , p. 720. 10.1007/s11096-008-9226-3 |
![]() |
Basra, M. K. A., Edmunds, O., Salek, Mir-saeed and Finlay, Andrew Yule ![]() |
![]() |
Hajjaj, F. M., Basra, M., Salek, Sam and Finlay, Andrew Yule ![]() |
![]() |
Basra, M. K. A., Fenech, R., Gatt, R. M., Salek, Sam and Finlay, Andrew Yule ![]() |
![]() |
Hajjaj, F. M., Basra, M., Salek, Sam and Finlay, Andrew Yule ![]() |
![]() |
Salek, Sam, Lewis-Smith, R. E., Ives, T. J. and Rake, K. M. 2008. How prevalent are opioid misuse and affective disorders in patients with fibromyalgia? Pharmacy World and Science 30 (5) , pp. 719-720. |
![]() |
Salek, Sam, Patel, J. and Schwartz, C. 2008. Evaluation of a rapid streptococcus testing service in the community pharmacy. Pharmacy World and Science 30 (5) , pp. 707-708. |
![]() |
Davies, Emily, Patel, C., Salek, Mir-saeed and Finlay, Andrew Yule ![]() |
![]() |
Salek, Sam, Chauhan, A., Hirako, M., McAuslane, N. and Walker, Stuart 2007. Does the global increase in post-marketing commitment ensure faster patient access to novel medicines? [Abstract]. Pharmacy World and Science 29 (5) , p. 449. 10.1007/s11096-007-9098-y |
![]() |
Mussen, Filip, Salek, Mir-saeed and Walker, Stuart 2007. A quantitative approach to benefit-risk assessment of medicines - part 1: The development of a new model using multi-criteria decision analysis. Pharmacoepidemiology and Drug Safety 16 (S1) , s2-s15. 10.1002/pds.1435 |
![]() |
Salek, Sam, Davies, E., Patel, Chirag Bipinbhai and Finlay, Andrew Yule ![]() |
![]() |
Salek, Sam, Roberts, Alaw and Finlay, Andrew Yule ![]() |
![]() |
Salek, Sam, Samson, R. and Gilbertson, J. 2007. Optimisation of discharge communication: a key to successful outcome. Pharmacy World & Science 29 (5) , pp. 474-475. |
![]() |
Salek, Sam, Shafie, A., Evans, R., Freedman, A., Birley, H., Browning, M. and Cohen, D. 2007. Can systematic assessment of patients' quality of life influence optimisation of HIV treatment? Pharmacy World & Science 29 (5) , pp. 490-491. |
![]() |
Salek, Sam, Shafie, A., Evans, R., Freedman, A., Birley, H., Browning, M. and Cohen, D. 2007. The case for HRQoL assessment: key to successful HIV treatment. Pharmacy World & Science 29 (5) , p. 491. |
![]() |
Salek, Sam, Suntharasaj, S. and Suntharasaj, T. 2007. Conceptualisation of a menopause-specific quality of life profile. Pharmacy World & Science 29 (5) , p. 495. |
![]() |
Tlusta, E., Kubena, A., Salek, Sam and Vlcek, J. 2007. Psychometric properties of the Czech version of the Quality of Life in Epilepsy Inventory (QOLIE-31). Epilepsy & Behavior 10 (3) , pp. 407-411. 10.1016/j.yebeh.2007.01.002 |
![]() |
Davies, E., Patel, Chirag, Salek, Mir-saeed and Finlay, Andrew Yule ![]() |
![]() |
Dixon, S., Walker, M. and Salek, Mir-saeed 2006. Incorporating carer effects into economic evaluation. PharmacoEconomics 24 (1) , pp. 43-53. |
![]() |
Shafie, A. A., Salek, Mir-saeed, Evans, R. H., Freedman, Andrew Robert, Birley, H., Browning, M. and Cohen, D. 2005. Self assessed health-related quality of life among HIV patient in UK [Abstract]. Value in Health 8 (6) , A62. 10.1016/S1098-3015(10)67329-9 |
![]() |
Katugampola, Ruwani, Thomas, C. L., Hongbo, Yan, Salek, Mir-saeed and Finlay, Andrew Yule ![]() |
![]() |
Al-Motarreb, Ahmed, Briancon, S, Al-Jaber, N, Al-Adhi, B., Al-Jailani, F., Salek, Mir-saeed and Broadley, Kenneth John ![]() |
![]() |
Hongbo, Yan, Thomas, Charles L., Harrison, Michael A., Salek, Mir-saeed and Finlay, Andrew Yule ![]() |
![]() |
Hongbo, Yan, Thomas, C. L., Harrison, M. A., Salek, Mir-saeed and Finlay, Andrew Yule ![]() |
![]() |
Salek, Mir-saeed, Finlay, AY, Lewis, James ![]() |
![]() |
Al-Mohammadi, A, Salek, Mir-saeed, Maughan, Timothy Stanley, Nicholls, P. J. and Mason, Malcolm David ![]() |
![]() |
Finlay, Ilora Gillian, Pratheepawanit, N. and Salek, Mir-saeed 2003. Monitoring self-reported quality-of-life among patients attending a palliative medicine outpatient clinic [Letter]. Palliative Medicine 17 (1) , pp. 83-84. 10.1191/0269216303pm663xx |
![]() |
Finlay, Andrew Yule ![]() |
![]() |
Pratheepawanit, N., Salek, Mir-saeed and Finlay, Ilora Gillian 1999. The applicability of quality-of-life assessment in palliative care: comparing two quality-of-life measures. Palliative Medicine 13 (4) , pp. 325-334. 10.1191/026921699670560921 |
![]() |
Almuzaini, A. S, Salek, Mir-saeed, Nicholls, P. J. and Alomar, B. A. 1998. The attitude of health care professionals toward the availability of hospice services for cancer patients and their carers in Saudi Arabia. Palliative Medicine 12 (5) , pp. 365-373. 10.1191/026921698667234126 |
![]() |
Salek, Mir-saeed, Finlay, Andrew Yule ![]() |
![]() |
Salek, Mir-saeed, Jones, H. and Coles, G. A. 1997. Assessment of quality of life in renal patients using the Renal Quality of Life Profile - a validation study [Abstract]. Quality of Life Research 6 (7-8) , p. 714. 10.1023/A:1018424519364 |
![]() |
Salek, Mir-saeed, Finlay, Andrew Yule ![]() |
![]() |
Salek, Mir-saeed 1997. Compendium of quality of life instruments [Abstract]. Quality of Life Research 6 (7-8) , pp. 713-714. |
![]() |
Blackford, S., Roberts, D., Salek, Mir-saeed and Finlay, Andrew Yule ![]() |
![]() |
Salek, Mir-saeed, Khan, G. and Finlay, Andrew Yule ![]() |
![]() |
Berth-Jones, J., Finlay, Andrew Yule ![]() |
![]() |
Salek, Mir-saeed, Finlay, Andrew Yule ![]() |
![]() |
Salek, Mir-saeed 1993. Health-related quality of life measurement:a new challenge for pharmacy practitioners. Journal of Pharmacy and Pharmacology 45 (S1) , pp. 387-392. |
![]() |
Sowden, J. M., Berth-Jones, J., Ross, J. S., Motley, R. J., Marks, R., Finlay, Andrew Yule ![]() |
![]() |
Finlay, Andrew Yule ![]() |
![]() |
Salek, Mir-saeed, Finlay, Andrew Yule ![]() |
![]() |
Salek, Mir-saeed, Luscombe, David Keith, Walker, Stuart, Grob, P. R., Vandenburg, M. J. and Lewis, Malcolm John 1988. Cardiovascular-disease and quality of life [Abstract]. British Journal of Clinical Pharmacology 26 (5) , 628P-628P. |
![]() |